ZAVA Global GmbH (SME)
ZAVA GL is a leading European telehealth platform with a decade of experience and more than 1 million active patients across Germany, UK, France and Ireland. With 150 employees ZAVA has delivered more than 7.5 million telemedicine consultations, pioneered asynchronous interactions, skin photo assessments as well as at-home test kits. The ZAVA telehealth platform specializes in end-to-end patient pathways through which healthcare professionals provide advice, treatments and a broad diagnostic portfolio of at-home test kits based on urine and blood samples with trusted partner laboratories across Europe. Test & Treat is the core value proposition to patients, the ZAVA mission is to build healthcare that is accessible and dependable, at a fraction of today’s cost.
ZAVA also provides the German healthcare system with one of the most popular certified video services for medical consultations: ZAVA sprechstunde.online offers over 30.0000 video consultations per month.
ZAVA’s role in the PANCAID project is to ensure the readiness for a digital end-to-end patient pathway. The new PANCAID digital solution of LBx Apps for IARs and PDAC patients and improved imaging analysis of cellular LBx components (e.g. CTCs) will primarily be brought to market by ZAVA.
Telemedicine Platform Hegestrasse 40
20251 Hamburg Germany